0002004745-24-000001.txt : 20240119 0002004745-24-000001.hdr.sgml : 20240119 20240119162827 ACCESSION NUMBER: 0002004745-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 EFFECTIVENESS DATE: 20240119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aether Therapeutics Inc. CENTRAL INDEX KEY: 0002004745 ORGANIZATION NAME: IRS NUMBER: 823723869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-502978 FILM NUMBER: 24545955 BUSINESS ADDRESS: STREET 1: 4200 MARATHON BOULEVARD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 760-783-3085 MAIL ADDRESS: STREET 1: 4200 MARATHON BOULEVARD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 D 1 primary_doc.xml X0708 D LIVE 0002004745 Aether Therapeutics Inc. 4200 MARATHON BOULEVARD SUITE 200 AUSTIN TX TEXAS 78756 760-783-3085 DELAWARE None None Corporation true John D Harris 4200 Marathon Boulevard Suite 200 Austin TX TEXAS 78756 Executive Officer Director Jon S Saxe 4200 Marathon Boulevard Suite 200 Austin TX TEXAS 78756 Executive Officer Director Wolfgang Sadee 4200 Marathon Boulevard Suite 200 Austin TX TEXAS 78756 Director Eric K Olson 2597 E Spring Canyon Drive Washington UT UTAH 84780 Director Biotechnology Decline to Disclose 06b false 2024-01-05 false true false 50000 Issuer Direct Sales Only None None None 4200 Marathon Boulevard Suite 200 Austin TX TEXAS 78756 UT UTAH false 6580866 4078010 2502856 The company has the right to raise an additional $2,502,856 but the offering shall not last more than one year. false 1 0 0 150000 true $150,000-$200,000 compensation paid to Chief Executive Officer. false Aether Therapeutics Inc. John D. Harris John D. Harris Chief Executive Officer 2024-01-19